| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Nov―21 |
A Biolayer Interferometry-Based SARS-COV-2 Mpro-Targeted Active Ingredients Recognition System: Construction and Application in Ligand Screening From Herbal Medicines |
Dai Zhang, Bing Han, Xiao-Fei Chen, Shuai Zhao, Wei-Xia Li, Hui Zhang, Ming-Liang Zhang, Meng-Qi Huo, Yong-Sheng Qiu, Ying-Jie Ren, Yao-Dong Zhang, Xian-Qing Ren, Wei Wang, Jin-Fa Tang |
| 2 |
[GO] |
2024―Nov―14 |
Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS-CoV-2 Spike Protein: Combining Pseudovirus Testing, Yeast Two-Hybrid, and UPLC-Q Exactive Orbitrap-MS Profiling |
Yujing Huang, Rufeng Luo, Chenjing Tian, Duntao Zu, Jianni Yang, Wenlin Chen, Dingqiang Huang, Siyan Duan, Shunxin Yan, Yujia Yuan, Shengrong Li, Haibo Zhou, Fulong Lin, Qinghui He, Junxia Zheng |
| 3 |
[GO] |
2024―Jan―16 |
DNA barcoding of herbal supplements on the US commercial market associated with the purported treatment of COVID-19 |
Calin M. Harris, Diane Y. Kim, Chevon R. Jordan, Miranda I. Miranda, Rosalee S. Hellberg |
| 4 |
[GO] |
2021―Sep―29 |
Instant determination of the artemisinin from various
Artemisia annua L
. extracts by LC-ESI-MS/MS and their
in-silico
modelling and
in vitro
antiviral activity studies against SARS-CoV-2 |
Kubra Dogan, Ebru Erol, Muge Didem Orhan, Zehra Degirmenci, Tugce Kan, Aysen Gungor, Belkis Yasa, Timucin Avsar, Yuksel Cetin, Serdar Durdagi, Mustafa Guzel |
|
